CELYAD ONCOLOGY Stock Falls By 20% In The Last 10 Sessions
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) dropped by a staggering 20.33% in 10 sessions from €1.23 to €0.98 at 16:09 EST on Monday, after five consecutive sessions in a row of losses. BEL 20 is rising 0.14% to €3,890.68, following the last session’s upward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a…